Search Site

ADNOC Drilling closes JV

It is a JV between ADNOC Drilling, SLB and Patterson UTI.

Boeing to boost 787 production

The firm will invest$1bn to ramp up production in South Carolina.

ADNOC signs deal with PETRONAS

Under the agreement, ADNOC will supply 1m tons of LNG per year.

Aramco-Horse Powertrain deal completed

An agreement for the purchase of 10% equity stake was signed in June 2024.

Roche to buy Poseida Therapeutics

The $1.5 billion deal is due to close in early 2025.

AlNeyadi conducts over 200 research experiments on board ISS

The UAE astronaut Sultan Al Neyadi returns to Earth with his fellow astronauts. (WAM)
  • These research experiments were held in collaboration with 10 international space agencies and 25 esteemed UAE and global universities.
  • The experiments covered a range of topics including the cardiovascular system, back pain, protein crystallisation growth, epigenetics, immune system,

ABU DHABI, UAE – Over the course of a six-month space mission on board the International Space Station (ISS), UAE astronaut Sultan AlNeyadi conducted over 200 advanced research experiments and studies that took about 585 hours.

These research experiments were held in collaboration with 10 international space agencies and 25 esteemed UAE and global universities.

The experiments covered a range of topics including the cardiovascular system, back pain, protein crystallisation growth, epigenetics, immune system, fluid dynamics, plant biology, human life sciences, material science, sleep analysis and radiation, advanced exploration technologies.

These experiments have been instrumental in helping the scientific community, researchers, and students across the world.

Al Neyadi is scheduled to return home from the ISS on Monday following his completion of the longest Arab space mission in history, spanning six months.

He also accomplished a number of firsts and became the first Arab to complete a seven-hour spacewalk.

AlNeyadi engaged in 19 educational and community outreach events called the “A Call from Space” series, in which over 10,000 people from all walks of life took part and interacted with the Emirati astronaut through live video calls and ham radio sessions.

The astronaut also engaged in an innovative Protein Crystal Growth Experiment (PCG) on board the Kibo module on the ISS.

The experiment was launched on the Space X-28 cargo mission and was installed by AlNeyadi.

The experiment theme was proposed by a research team from the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) in the UAE in collaboration with the Harvard Medical School in the USA and in compliance with a collaborative agreement between the UAE Space Agency, MBRSC and Japan Aerospace Exploration Agency (JAXA).

AlNeyadi, along with his Expedition 69 crew members, have made significant strides in microgravity research, featuring a range of pioneering scientific investigations, including on cardiovascular system, plant biology, material science, fluid science and sleep analysis, among others.

He completed an experiment on the ISS that seeks to reveal more about sleep quality on extended missions.

The Emirati astronaut had successfully conducted the experiment, which saw him wear a specially-designed headband to capture key data.

The dreams experiment employs the ‘dry-EEG (electroencephalography)’ system to monitor sleep patterns of astronauts in the microgravity environment on the space station.

The unique conditions aboard the space station, where astronauts witness 16 sunrises and sunsets each day, can disrupt the natural day to night cycle, significantly affecting sleep patterns.

“This research helps us learn more about sleep disorders in humans and the health problems they experience on earth,” he said.

As part of set of experiments on the ISS, AlNeyadi took part in the Cardinal Heart 2.0 study by Stanford University.

Through this experiment, he said, “We are exploring the effects of clinical drugs on heart cells in microgravity using heart tissues.” Discoveries from such studies could help prevent cardiovascular risk for space explorers and patients with heart disease on Earth.

AlNeyadi also contributed to the Cardiobreath experiment on the ISS.

The experiment is a critical analysis of the impact of microgravity on cardiovascular and respiratory functions and was conducted in collaboration with the Canadian Space Agency (CSA), Simon Fraser University and The University of North Dakota.

As part of the UAE Astronaut Programme Grants Research Programme, MBRSC has selected two research projects from the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU).

AlNeyadi also participated in the host-pathogen experiment to analyse the reaction between astronauts’ immunity and the microbial pathogens on the ISS.

This experiment was conducted in collaboration with NASA’s Johnson Space Centre. The results of the study would be analysed through AlNeyadi’s DNA samples collected aboard the ISS and on Earth.

The host-pathogen study examines the interaction between astronauts and microbial pathogens that may be present within the environment of the space station through biological sample collection.

This will offer an overall understanding of the effects of stress hormones and latent virus reactivation in the astronaut’s immunity system.